CRP and heart failure: This study observed that HIF-PH inhibitor therapy resulted in significant improvements in several clinical parameters associated with heart failure, including reductions in plasma B-type natriuretic peptide and C-reactive protein levels, along with an increased estimated glomerular filtration rate.